MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20243429

April 7, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1%(0.4ml:0.4mg)

化学药品

April 7, 2024

Company Information

Applicant Company

浙江省湖州市湖州经济技术开发区龙溪街道王母山路1800 号1 号楼二层207

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath